{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:14:14Z","timestamp":1790691254774,"version":"4.1.0"},"reference-count":19,"publisher":"Scientific Scholar","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"\n Background & objectives:<\/jats:title>\n Sepsis due to multidrug-resistant Gram-negative pathogens is a challenge for clinicians and microbiologists and has led to use of parenteral colistin. There is a paucity of data regarding safety and efficacy of intravenous colistin use in neonates. The objective of this retrospective analysis was to study the efficacy and safety of intravenous colistin in the treatment of neonatal sepsis.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n An audit of the data from neonates, admitted to a neonatal intensive care unit of a tertiary care hospital during January 2012 to December 2012, and who received intravenous colistin was carried out.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Sixty two neonates received intravenous colistin (52 preterm and 10 term) for the treatment of pneumonia, bloodstream infections and meningitis. The isolated pathogens in decreasing order of frequency were Acinetobacter baumannii<\/jats:italic>, Klebsiella pneumonia<\/jats:italic> and Pseudomonas aeruginosa<\/jats:italic>. Of the total 62 neonates, 41 (66.12%) survived and 21 (33.87%) died. Significantly higher mortality was observed in neonates with lower body weights (P<\/jats:italic> < 0.05). A significant association of mortality was found in those with sepsis due to Klebsiella<\/jats:italic> species. Only one of seven with this infection survived as against 15 of the 23 who grew other organisms [P<\/jats:italic> = 0.03; crude odds ratio = 11.25 (1.2, 110.5)]. None of the neonates developed neurotoxicity or nephrotoxicity.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n This retrospective study in neonates with sepsis showed that intravenous colistin was safe and effective in the treatment of neonatal sepsis. Further, well\u2013controlled, prospective clinical trials need to be done to corroborate these findings.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0971-5916.198682","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T07:49:15Z","timestamp":1484898555000},"page":"433-439","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":21,"title":["An audit of colistin use in neonatal sepsis from a tertiary care centre of a resource-limited country"],"prefix":"10.25259","volume":"144","author":[{"given":"Bonny","family":"Jasani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridharan","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Nanavati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya J.","family":"Gogtay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmila","family":"Thatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-17-20241212","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00006454-199010000-00039","article-title":"Bacteriology of neonatal sepsis","volume":"9","author":"Klein","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"R2-17-20241212","doi-asserted-by":"crossref","first-page":"F220","DOI":"10.1136\/adc.2002.022863","article-title":"Neonatal sepsis: an international perspective","volume":"90","author":"Vergnano","year":"2005","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R3-17-20241212","first-page":"45","article-title":"Neonatal sepsis: past, present and future: a review article","volume":"5","author":"Tripathi","year":"2010","journal-title":"Internet J Med Update"},{"key":"R5-17-20241212","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7883\/yoken.JJID.2009.46","article-title":"Blood culture confirmed bacterial sepsis in neonates in a North Indian tertiary care center: changes over the last decade","volume":"62","author":"Sundaram","year":"2009","journal-title":"Jpn J Infect Dis"},{"key":"R6-17-20241212","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.5897\/AJMR2012.2307","article-title":"Multidrug resistant microorganisms causing neonatal septicemia: in a tertiary care hospital Lahore, Pakistan","volume":"7","author":"Hannan","year":"2013","journal-title":"Afr J Microbiol Res"},{"key":"R7-17-20241212","first-page":"18","article-title":"Multidrug-resistant Gram-negative bacteria: trends, risk factors, and treatment","volume":"41","author":"Engel","year":"2009","journal-title":"Emerg Med"},{"key":"R8-17-20241212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2004.10.001","article-title":"Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria","volume":"25","author":"Li","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"R9-17-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1465-0691.2004.1004.x","article-title":"The need for new antibiotics","volume":"10","author":"Livermore","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"R10-17-20241212","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"R11-17-20241212","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.50.4270","article-title":"Efficacy and safety of colistin in the treatment of infections caused by multi-drug resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis","volume":"50","author":"Durakovic","year":"2011","journal-title":"Intern Med"},{"key":"R12-17-20241212","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2146\/ajhp060473","article-title":"Polymyxin antibiotics for Gram-negative infections","volume":"64","author":"Arnold","year":"2007","journal-title":"Am J Health Syst Pharm"},{"key":"R13-17-20241212","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e3182064bfe","article-title":"Intravenous colistin administration in neonates","volume":"30","author":"Jajoo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R14-17-20241212","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00431-009-1137-3","article-title":"Colistin administration to pediatric and neonatal patients","volume":"169","author":"Iosifidis","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R17-17-20241212","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ijantimicag.2008.10.021","article-title":"Systemic colistin use in children without cystic fibrosis: a systematic review of the literature","volume":"33","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R18-17-20241212","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00228-013-1493-9","article-title":"Pharmacokinetics of colistin in critically ill patients with multidrug-resistant Gram-negative bacilli infection","volume":"69","author":"Karnik","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"R20-17-20241212","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.01020-10","article-title":"Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan","volume":"55","author":"Marchaim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R21-17-20241212","doi-asserted-by":"crossref","first-page":"5103","DOI":"10.1128\/AAC.01064-12","article-title":"The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic\/pharmacodynamic model","volume":"56","author":"Deris","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"R22-17-20241212","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1128\/AAC.00670-10","article-title":"Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model","volume":"55","author":"Hilliard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R23-17-20241212","doi-asserted-by":"crossref","first-page":"F182","DOI":"10.1136\/archdischild-2011-300097","article-title":"Multi-drug resistant Gram negative bacilli causing early neonatal sepsis in India","volume":"97","author":"Viswanathan","year":"2012","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201644030-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:58:19Z","timestamp":1751497099000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/an-audit-of-colistin-use-in-neonatal-sepsis-from-a-tertiary-care-centre-of-a-resource-limited-country\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.198682","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}